UConn Health Center, Farmington, CT, October 21st , 2017. “New Approaches to Decreasing Anxiety and Addressing Behavioral Challenges in Fragile X” is for families, educators, therapists, and providers who care for children and adults with fragile x-associated disorders and autism spectrum disorders .
Workshop topics include:
“Foundations have not Changed, but What is New?”|
“Shifting Behavior Through Appropriate Supports”
“Clinics Update and Current Research”
“Anxiety – New Thoughts in Addressing the Biggest Challenge”
“Questions and Answers: Panel Discussion”
Fees apply, registration is required to 860-233-1904 or CentralCT@fragilex.org or visit https://give.fragilex.org/farmington/events/connecticut-fragile-x-conference-new-approaches-to-decreasing-anxiety-addressing-behavioral-challenges-fragile-x/e142350?mc_cid=4fd31f5517&mc_eid=c42afe6926
About the speakers
Karen Riley, PhD – Dean and Professor at the Morgridge College of Education at the University of Denver. Dr. Riley currently serves on the Clinical and Scientific Advisory Board for the National Fragile X Foundation. She has over 15 years of experience in teaching and administration of early childhood special education programs. She has an additional 15 years of experience working with children who have neurodevelopmental disorders and their families. She has been and is currently involved in several psycho-pharmacological studies and other research projects related to fragile X syndrome and other neurodevelopmental disorders. Particular areas of interest and expertise include assessment and intervention of infants and preschoolers, curriculum development, school consultation, behavioral interventions and low incidence disabilities. She lectures extensively throughout the US, as well as internationally, on behavioral and educational interventions for children with neurodevelopmental disorders primarily those with fragile X syndrome.
Jonathan Picker, MBChB, PhD – Joint Appointment between Clinical Genetics and Child and Adolescent Psychiatry at Boston Children’s Hospital (BCH); Asst. Professor, Harvard Medical School. Dr. Picker heads the BCH Fragile X Program, providing individuals and families affected by fragile X with evaluation and care supported by the latest medical, educational, and research knowledge. Dr. Picker was a Founding Member of the International Fragile X Clinical & Research Consortium and the chairman of its clinical committee responsible for the development of most of the consensus documents on clinical practice. He is also the co-founder and co-director of the BCH Pharmacogenomics Clinic, which looks at genes that affect an individual’s responses to medications and their likelihood of developing side effects; this is especially important for those who have had poor and unexpected responses from medicines.
Sharyn Lincoln, MS, CGC – Licensed Genetic Counselor, Clinical Coordinator, Fragile X Program, Boston Children’s Hospital (BCH). She is the program coordinator and a counselor for the Boston Children’s Hospital Fragile X Program. Ms. Lincoln is a member of the Fragile X Clinical and Research Consortium (FXCRC) Clinical Committee and Research Committee. She is in close communication with the New England Fragile X Community Support Network groups and actively participates in local conferences and events. In addition to her clinical responsibilities, Ms. Lincoln is the BCH site coordinator for the Undiagnosed Diseases Network.